We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$41B
AUM Growth
-$3.23B
(-7.3%)
Cap. Flow
-$1.04B
Cap. Flow
% of AUM
-2.54%
Top 10 Holdings %
Top 10 Hldgs %
14.31%
Holding
2,407
New
233
Increased
1,091
Reduced
839
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$119M |
| 2 |
Valero Energy
VLO
|
+$117M |
| 3 |
Chevron
CVX
|
+$89.6M |
| 4 |
Booking.com
BKNG
|
+$88.5M |
| 5 |
Mastercard
MA
|
+$85.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allstate
ALL
|
+$109M |
| 2 |
Moderna
MRNA
|
+$105M |
| 3 |
Goldman Sachs
GS
|
+$97.9M |
| 4 |
Lennar Class A
LEN
|
+$81M |
| 5 |
Emerson Electric
EMR
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.89% |
| 2 | Healthcare | 15.51% |
| 3 | Financials | 11.51% |
| 4 | Consumer Discretionary | 11.48% |
| 5 | Industrials | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
1701
DELISTED
Mersana Therapeutics
MRSN
| $611K | ﹤0.01% |
3,617
+2,681
| +286% | +$436K |
|
1702
Sally Beauty Holdings
SBH
$1.58B
| $609K | ﹤0.01% |
48,362
+16,786
| +53% | +$233K |
|
|
ZUO
1703
DELISTED
Zuora, Inc.
ZUO
| $608K | ﹤0.01% |
+82,426
| New | +$711K |
|
1704
Foghorn Therapeutics
FHTX
$391M
| $606K | ﹤0.01% |
+70,587
| New | +$908K |
|
1705
Insmed
INSM
$29B
| $601K | ﹤0.01% |
27,898
+19
| +0.1% | +$456 |
|
|
CHS
1706
DELISTED
Chicos FAS, Inc.
CHS
| $600K | ﹤0.01% |
123,872
+104,388
| +536% | +$580K |
|
1707
Stride
LRN
$3.29B
| $599K | ﹤0.01% |
14,248
+1,576
| +12% | +$63.5K |
|
1708
Santander
BSBR
$43.1B
| $598K | ﹤0.01% |
106,025
+6,632
| +7% | +$37.2K |
|
|
PGTI
1709
DELISTED
PGT, Inc.
PGTI
| $598K | ﹤0.01% |
+28,539
| New | +$587K |
|
1710
Alico
ALCO
$307M
| $596K | ﹤0.01% |
+21,109
| New | +$713K |
|
1711
Kinetik
KNTK
$4.11B
| $594K | ﹤0.01% |
18,240
+3,094
| +20% | +$114K |
|
1712
Universal Corp
UVV
$1.15B
| $591K | ﹤0.01% |
12,832
+8,621
| +205% | +$451K |
|
1713
Mitek Systems
MITK
$836M
| $590K | ﹤0.01% |
64,419
+42,381
| +192% | +$425K |
|
1714
Axalta
AXTA
$7.98B
| $588K | ﹤0.01% |
27,939
-130,883
| -82% | -$3.22M |
|
1715
Nature's Sunshine
NATR
$277M
| $588K | ﹤0.01% |
71,365
-40,146
| -36% | -$399K |
|
1716
Eastern Bankshares
EBC
$5.29B
| $587K | ﹤0.01% |
29,902
-30,877
| -51% | -$618K |
|
1717
Entravision Communication
EVC
$852M
| $584K | ﹤0.01% |
146,986
-148,910
| -50% | -$737K |
|
1718
CNX Resources
CNX
$5.35B
| $583K | ﹤0.01% |
37,560
+11,220
| +43% | +$190K |
|
1719
Enerpac Tool Group
EPAC
$1.91B
| $582K | ﹤0.01% |
32,617
+11,070
| +51% | +$215K |
|
1720
Ethan Allen Interiors
ETD
$602M
| $581K | ﹤0.01% |
27,474
+3,448
| +14% | +$80.5K |
|
1721
Anika Therapeutics
ANIK
$284M
| $580K | ﹤0.01% |
24,390
+9,685
| +66% | +$223K |
|
1722
Fox Factory Holding Corp
FOXF
$905M
| $580K | ﹤0.01% |
7,330
+951
| +15% | +$88K |
|
1723
TechTarget
TTGT
$271M
| $578K | ﹤0.01% |
9,766
+15
| +0.2% | +$964 |
|
1724
Myers Industries
MYE
$1.21B
| $576K | ﹤0.01% |
34,998
+25,373
| +264% | +$523K |
|
1725
ZipRecruiter
ZIP
$405M
| $576K | ﹤0.01% |
+34,883
| New | +$608K |
|
Similar funds
VGA
AQR Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, AQR Capital Management held 2,407 positions worth $41B, down 7.3% from $44.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q3 2022 filing shows 233 new, 1,091 increased, 839 reduced and 232 closed positions. Its largest new stake was Applovin: 596,316 shares worth $11.6M. The largest sale was Allstate, an estimated $109M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q3 2022 buy was Applovin: 596,316 shares worth $11.6M.
- AQR Capital Management added most to Tesla in Q3 2022, an estimated $119M increase.
- AQR Capital Management's biggest Q3 2022 reduction was Allstate, cutting an estimated $109M.
- AQR Capital Management fully exited Baidu in Q3 2022, selling an estimated $31.3M.
- AQR Capital Management's ten largest holdings make up 14% of its $41B portfolio in Q3 2022.
- AQR Capital Management opened 233 new positions and closed 232 in Q3 2022.
- AQR Capital Management's portfolio value fell 7.3% quarter-over-quarter to $41B.
Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.